Bryan Johnson Reveals His Stomach Is Attacking Itself With a Hidden Disease Millions May Have

A Shocking Diagnosis From the Man Who Wants to Live Forever

Longevity entrepreneur Bryan Johnson, who has built a global following through his ambitious anti-aging regimen and "Don't Die" movement, has revealed that he has been diagnosed with autoimmune gastritis. For a man whose entire brand is built around defeating the aging process, the announcement was a jarring reminder that even the most meticulously monitored body can harbor invisible threats. Johnson shared the news on June 30 in a lengthy post on X, writing bluntly: "My stomach is eating itself."

Johnson, 48, explained that autoimmune gastritis (AIG) is a chronic condition that damages the stomach lining and can lead to iron deficiency, anemia, vitamin B12 deficiency, and an increased risk of stomach cancer. He said the disease had likely begun developing years ago alongside the autoimmune thyroid condition he was diagnosed with at the age of 21. What makes the revelation particularly striking is that Johnson — a man who submits himself to an extraordinary battery of medical tests — still went years without catching it.

How the Diagnosis Was Finally Uncovered

The diagnosis came after years of persistently low iron levels despite dietary changes and getting supplements. Doctors initially investigated whether hidden blood loss from bowel cancer or polyps was responsible for his iron deficiency by performing a colonoscopy, which returned normal results. It was only through deeper, more targeted investigation that the real culprit emerged.

Fifteen minutes before one procedure, blood results returned showing elevated levels of anti-parietal-cell antibodies — at roughly five times the upper limit of normal. His team had ordered five biopsies taken from three regions of his stomach. The biopsies were the critical piece — had they not been ordered, the endoscopy would have been completed and AIG would have remained undiagnosed, as there were no visual signatures of the condition. Two days later, biopsy results came in showing clear signs of early autoimmune gastritis: early atrophy confined to the acid-producing lining, with the rest of the stomach still spared.

Why This Disease Is So Easy to Miss

According to the U.S. National Institute of Diabetes and Digestive and Kidney Diseases, autoimmune gastritis occurs when the immune system mistakenly attacks healthy cells in the stomach lining. The condition is chronic and typically non-erosive, gradually damaging the stomach's acid-producing parietal cells, which are important for digestion. It affects an estimated 2–5% of people, and likely more, because it hides and is challenging to diagnose. It's usually silent for years, surfacing only once the stomach has atrophied enough to do real damage: iron deficiency first, then B12 deficiency, then anemia from both, and over a long horizon, raised stomach-cancer risk.

In one study of people with precancerous gastric lesions, roughly 18% carried the autoimmune antibodies, and only about 1% had ever been diagnosed. The earliest clue — low ferritin — is the one standard medicine tends to overlook. Low iron stores get normalized and rarely investigated at all when anemia hasn't yet appeared. Johnson noted that this blind spot hid his own condition for a decade. His situation was actually three linked problems: the iron deficiency, the autoimmune gastritis driving it, and autoimmune thyroid disease alongside it — with low iron impairing thyroid hormone conversion, and an underactive thyroid impairing how the body uses iron. Each made the other harder to fix.

Johnson's Plan: Manage It, Then Try to Cure It

Johnson revealed that a 1,000mg iron infusion successfully corrected his longstanding iron deficiency while doctors continue monitoring the disease's progression. But he isn't stopping at management. Rather than accepting the diagnosis, Johnson said he intends to challenge conventional treatment approaches, writing that his team is going to try to solve his AIG — a plan that includes regular monitoring, repeat biopsies, and experimental therapies targeting the underlying autoimmune process.

Johnson argued that modern medicine has normalized too many conditions that erode health, shrinking the goal to monitoring and management while a cure is rarely even attempted — and that most of these verdicts were handed down decades ago, in an era that predates nearly all current technology and science. He believes that in the age of AI, multiomics, and custom-built DNA, proteins, and cells, no condition should be presumed incurable simply because no one has yet tried to cure it with today's tools. Whether Johnson can actually push the science forward on AIG remains to be seen — but his diagnosis has already done something valuable: it's put a poorly understood, widely underdiagnosed disease on millions of people's radar.